AstraZeneca reports ‘highly effective’ vaccine
The drugmaker AstraZeneca announced on Monday that an early analysis of some of its late-stage clinical trials, conducted in the United Kingdom and Brazil, showed...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The drugmaker AstraZeneca announced on Monday that an early analysis of some of its late-stage clinical trials, conducted in the United Kingdom and Brazil, showed...
Dr. Carine Boustany has been named Global Head, Development Science and Head, Development Site U.S. at Boehringer Ingelheim, beginning January 1, 2021. Dr. Boustany sits on...
Halda Therapeutics, a Branford-based biotech company, plans to move to New Haven after signing a lease for a 9,800 square-foot lab and office space in in...
Yale University has added 13 states to the national rollout of its much-anticipated SalivaDirect COVID-19 test. Yale has now approved more than 30 independent labs...
A New Haven-based biopharmaceutical company has launched development efforts for a drug to treat a rare, life-threatening disorder that can cause uncontrolled bleeding in fetuses...
The drug maker Pfizer said on Wednesday that its coronavirus vaccine was 95 percent effective and had no serious side effects — the first set...
The Massachusetts-based company Moderna has reported promising preliminary results from its coronavirus vaccine trial. Coming just a week after similar news from Pfizer and BioNTech,...
If the Pfizer-involved COVID-19 vaccine is successful in beating the spread of the pandemic that has gripped the nation for nearly 10 months, it will...
NanoViricides has engaged Calvert Labs, a contract research organization, for performing the safety pharmacology studies of its clinical drug candidate for the treatment of COVID-19....
CytoVeris has appointed Dr. Michael Fenn, Ph.D., Harvard University, as the newest member of its Scientific Advisory Board (SAB). Dr. Fenn serves as the Director...